Hot Life Science Investor Mandate 1: PE Group with AUM Over $1b Plans to Grow in 2013 – January 15, 2013

15 Jan

A private equity group headquartered in the US is currently deploying assets from their most recent fund, which closed at nearly $400 million, bringing the firm’s total assets under management to over $1 billion. The group, which also has offices in China, has been very actively seeking and investing in new companies in the life sciences space, and still has a great deal of dry powder on hand from their latest close. They have made several new investments within the last two months, and anticipate that they will be investing at around the same pace throughout 2013 if compelling opportunities continue to arise. The firm typically allocates in the millions of dollars, but has written tickets up to $50 million in the past.

The firm is interested in biotech firms creating therapeutics, medical technology companies that develop medical devices, and specialty pharmaceutical companies. In the biotech therapeutics and diagnostics space, the firm is opportunistic in terms the indication of a product that a firm is targeting, and is especially interested in firms that are developing drugs for the treatment of orphan diseases.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: